Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression

L. Mao, J. Ding, A. Perdue, L. Yang, Y. Zha, Mingqiang Ren, Shuang Huang, H. Cui, Hanfei Ding

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The Polycomb transcription repressor BMI1 is highly expressed in human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neuroblastoma cell lines. The molecular basis of BMI1 action in neuroblastoma cells is not well understood. Here we report that BMI1 has a critical role in stabilizing cyclin E1 by repressing the expression of FBXW7, a substrate-recognition subunit of the SCF E3 ubiquitin ligase that targets cyclin E1 for degradation. BMI1 binds to the FBXW7 locus in vivo and represses its mRNA expression. Overexpression of cyclin E1 or abrogation of FBXW7 induction rescues the cell-death phenotype of BMI1 knockdown. Moreover, MYCN, an oncoprotein in the pathogenesis of high-risk neuroblastomas, is able to counteract the death-inducing effect of BMI1 knockdown by activating CCNE1 transcription. We further show that high cyclin E1 expression is associated with Stage 4 neuroblastomas and poor prognosis in patients. These findings suggest a molecular mechanism for the oncogenic activity of BMI1 and MYCN in neuroblastoma pathogenesis and progression by maintaining cyclin E1 levels.

Original languageEnglish (US)
Pages (from-to)3785-3795
Number of pages11
JournalOncogene
Volume31
Issue number33
DOIs
StatePublished - Aug 16 2012

Fingerprint

Cyclins
Neuroblastoma
SKP Cullin F-Box Protein Ligases
Ubiquitin-Protein Ligases
Oncogene Proteins
Cell Death
Phenotype
Cell Line
Messenger RNA

Keywords

  • BMI1
  • FBXW7
  • MYCN
  • cyclin E1
  • neuroblastoma

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression. / Mao, L.; Ding, J.; Perdue, A.; Yang, L.; Zha, Y.; Ren, Mingqiang; Huang, Shuang; Cui, H.; Ding, Hanfei.

In: Oncogene, Vol. 31, No. 33, 16.08.2012, p. 3785-3795.

Research output: Contribution to journalArticle

Mao, L, Ding, J, Perdue, A, Yang, L, Zha, Y, Ren, M, Huang, S, Cui, H & Ding, H 2012, 'Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression', Oncogene, vol. 31, no. 33, pp. 3785-3795. https://doi.org/10.1038/onc.2011.536
Mao, L. ; Ding, J. ; Perdue, A. ; Yang, L. ; Zha, Y. ; Ren, Mingqiang ; Huang, Shuang ; Cui, H. ; Ding, Hanfei. / Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression. In: Oncogene. 2012 ; Vol. 31, No. 33. pp. 3785-3795.
@article{861567d72e204df8955b0303aa08bdb1,
title = "Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression",
abstract = "The Polycomb transcription repressor BMI1 is highly expressed in human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neuroblastoma cell lines. The molecular basis of BMI1 action in neuroblastoma cells is not well understood. Here we report that BMI1 has a critical role in stabilizing cyclin E1 by repressing the expression of FBXW7, a substrate-recognition subunit of the SCF E3 ubiquitin ligase that targets cyclin E1 for degradation. BMI1 binds to the FBXW7 locus in vivo and represses its mRNA expression. Overexpression of cyclin E1 or abrogation of FBXW7 induction rescues the cell-death phenotype of BMI1 knockdown. Moreover, MYCN, an oncoprotein in the pathogenesis of high-risk neuroblastomas, is able to counteract the death-inducing effect of BMI1 knockdown by activating CCNE1 transcription. We further show that high cyclin E1 expression is associated with Stage 4 neuroblastomas and poor prognosis in patients. These findings suggest a molecular mechanism for the oncogenic activity of BMI1 and MYCN in neuroblastoma pathogenesis and progression by maintaining cyclin E1 levels.",
keywords = "BMI1, FBXW7, MYCN, cyclin E1, neuroblastoma",
author = "L. Mao and J. Ding and A. Perdue and L. Yang and Y. Zha and Mingqiang Ren and Shuang Huang and H. Cui and Hanfei Ding",
year = "2012",
month = "8",
day = "16",
doi = "10.1038/onc.2011.536",
language = "English (US)",
volume = "31",
pages = "3785--3795",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "33",

}

TY - JOUR

T1 - Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression

AU - Mao, L.

AU - Ding, J.

AU - Perdue, A.

AU - Yang, L.

AU - Zha, Y.

AU - Ren, Mingqiang

AU - Huang, Shuang

AU - Cui, H.

AU - Ding, Hanfei

PY - 2012/8/16

Y1 - 2012/8/16

N2 - The Polycomb transcription repressor BMI1 is highly expressed in human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neuroblastoma cell lines. The molecular basis of BMI1 action in neuroblastoma cells is not well understood. Here we report that BMI1 has a critical role in stabilizing cyclin E1 by repressing the expression of FBXW7, a substrate-recognition subunit of the SCF E3 ubiquitin ligase that targets cyclin E1 for degradation. BMI1 binds to the FBXW7 locus in vivo and represses its mRNA expression. Overexpression of cyclin E1 or abrogation of FBXW7 induction rescues the cell-death phenotype of BMI1 knockdown. Moreover, MYCN, an oncoprotein in the pathogenesis of high-risk neuroblastomas, is able to counteract the death-inducing effect of BMI1 knockdown by activating CCNE1 transcription. We further show that high cyclin E1 expression is associated with Stage 4 neuroblastomas and poor prognosis in patients. These findings suggest a molecular mechanism for the oncogenic activity of BMI1 and MYCN in neuroblastoma pathogenesis and progression by maintaining cyclin E1 levels.

AB - The Polycomb transcription repressor BMI1 is highly expressed in human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neuroblastoma cell lines. The molecular basis of BMI1 action in neuroblastoma cells is not well understood. Here we report that BMI1 has a critical role in stabilizing cyclin E1 by repressing the expression of FBXW7, a substrate-recognition subunit of the SCF E3 ubiquitin ligase that targets cyclin E1 for degradation. BMI1 binds to the FBXW7 locus in vivo and represses its mRNA expression. Overexpression of cyclin E1 or abrogation of FBXW7 induction rescues the cell-death phenotype of BMI1 knockdown. Moreover, MYCN, an oncoprotein in the pathogenesis of high-risk neuroblastomas, is able to counteract the death-inducing effect of BMI1 knockdown by activating CCNE1 transcription. We further show that high cyclin E1 expression is associated with Stage 4 neuroblastomas and poor prognosis in patients. These findings suggest a molecular mechanism for the oncogenic activity of BMI1 and MYCN in neuroblastoma pathogenesis and progression by maintaining cyclin E1 levels.

KW - BMI1

KW - FBXW7

KW - MYCN

KW - cyclin E1

KW - neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=84865270072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865270072&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.536

DO - 10.1038/onc.2011.536

M3 - Article

C2 - 22120721

AN - SCOPUS:84865270072

VL - 31

SP - 3785

EP - 3795

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 33

ER -